67 E. Evelyn Avenue, Suite #6
Mountain View, California 94041
Jan Medical has developed the first and only portable brain sensing device designed to enable timely determination of ischemic stroke. With the Nautilus NeuroWave determinations can be made in minutes.
Most ischemic strokes are treatable neurological emergencies. However, every second counts. Unfortunately, today's standard of brain imaging is largely ineffective at detecting ischemic stroke in the brief therapeutic window available to treating physicians. While advanced imaging options exist that improve sensitivity, they remain deficient, take even more time than computed tomography (CT) and are not widely available.
Patients recovering from a ruptured cerebral aneurysm are susceptible to life threatening cerebral vasospasm for up to 21 days post stroke. The current standard of vigilance involves only daily snapshot assessments with ultrasound and fairly imprecise clinical assessments. Jan Medical's Nautilus NeuroWave is designed to enable continuous monitoring of stroke patients in order to detect cerebral vascular vasospasm as it occurs and progresses.
The Nautilus NeuroWave is also being evaluated for possible reliable detection of traumatic brain injuries, including concussions. Concussions are not detected anatomically by any current technology, leaving doctors and other health providers without hard data upon which to base treatment or clearance to return to activity.
The Nautilus NeuroWave is designed to rapidly provide reliable data upon which clinicians can act to treat ischemic stroke patients, identify brain trauma and other cerebrovascular abnormalities, and continuously monitor patients recovering from stroke.
Jan Medical is leveraging the US Navy's expertise in decoding threats to submarines by using technology based on underwater sensors
that are nearly identical to those used in the Jan Medical platform.